MedTrace Logo

High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children

NCT05043116 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2025-04-16

No results posted yet for this study

Summary

To investigate whether high-dose vitamin D supplementation may have a beneficial effect on secondary prevention in preschool children (1-5 years of age), with respiratory infections being the primary cause of acute exacerbations with asthma-like symptoms.

Conditions

  • Asthma in Children

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol D3

2000 IU of Vitamin D provided as oral suspension for one year

OTHER

Oral placebo suspension

Oral suspension with no active substance tasting like the active supplement.

Sponsors & Collaborators

  • Copenhagen Studies on Asthma in Childhood

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
71 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2028-10-16
Completion
2031-10-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05043116 on ClinicalTrials.gov